HIGHLIGHTS
- who: Sonia Alonso from the (UNIVERSITY) have published the research work: Upcoming pharmacological developments in chronic hepatitis B: can we glimpse a cure on the horizon?, in the Journal: (JOURNAL)
- what: Recent developments of new highly effective antiviral therapy against HCV infection have fueled the research for a cure of chronic HBV infection or HBsAg loss.
SUMMARY
NAs (Entecavir and Tenofovir), inhibit the HBV polymerase activity and thus viral_replication, but with no major impact on cccDNA which is used to transcribe viral RNAs. The vast majority of patients require lifelong treatment . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.